Progressive chronic lymphocytic leukemia

Progressive chronic lymphocytic leukemia represents an active, advancing clinical phase of a hematologic malignancy characterized by the clonal proliferation and accumulation of mature-appearing, immunologically dysfunctional B lymphocytes primarily affecting the peripheral blood, bone marrow, spleen, and lymph nodes Unlike stable or indolent disease, this progressive state is defined by worsening tumor burden and clinical deterioration that warrants therapeutic intervention

Progressive chronic lymphocytic leukemia represents an active, advancing clinical phase of a hematologic malignancy characterized by the clonal proliferation and accumulation of mature-appearing, immunologically dysfunctional B lymphocytes primarily affecting the peripheral blood, bone marrow, spleen, and lymph nodes

Unlike stable or indolent disease, this progressive state is defined by worsening tumor burden and clinical deterioration that warrants therapeutic intervention Hallmarks include progressive marrow failure presenting as worsening anemia or thrombocytopenia, rapidly doubling lymphocytosis, massive or symptomatic lymphadenopathy and splenomegaly, or debilitating constitutional B symptoms such as unintentional weight loss, severe fatigue, fevers, and night sweats

Hallmarks include progressive marrow failure presenting as worsening anemia or thrombocytopenia, rapidly doubling lymphocytosis, massive or symptomatic lymphadenopathy and splenomegaly, or debilitating constitutional B symptoms such as unintentional weight loss, severe fatigue, fevers, and night sweats